New antibody drug continues to show promise for treatment of HIV

Antibody therapy may offer an alternative to standard HIV treatments, which require a strict regimen and can cause complications in the long-term. New results from a clinical trial show that the 3BNC117 antibody can significantly delay the virus from rebounding in patients taken off their current medications. More »
Source: The Rockefeller University Newswire - Category: Biomedical Science Authors: Tags: Science News 3BNC117 antibody therapy clinical trial HIV Michel C. Nussenzweig Michel Nussenzweig Source Type: news